G0S2 and chronic myelogenous leukemia, BCR-ABL1 positive: Thus, the role of G0S2 as a tumour suppressor in CML and in normal myeloid differentiation could depend on its LPAAT enzymatic activity and the ability to synthesise PA (Figure 8), which will be the topic of future investigation.